• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自人乳头瘤病毒16型的E6和E7癌蛋白通过整个Sp1识别序列诱导人转化生长因子β1启动子的激活。

E6 and E7 oncoproteins from human papillomavirus type 16 induce activation of human transforming growth factor beta1 promoter throughout Sp1 recognition sequence.

作者信息

Peralta-Zaragoza Oscar, Bermúdez-Morales Víctor, Gutiérrez-Xicotencatl Lourdes, Alcocer-González Juan, Recillas-Targa Félix, Madrid-Marina Vicente

机构信息

Division of Molecular Biology of Pathogens, National Institute of Public Health, Cuernavaca, Mexico.

出版信息

Viral Immunol. 2006 Summer;19(3):468-80. doi: 10.1089/vim.2006.19.468.

DOI:10.1089/vim.2006.19.468
PMID:16987065
Abstract

Human Papillomavirus (HPV) infection is the main etiologic agent of cervical cancer and HPV E6 and E7 oncogenes trans-regulate many cellular genes. An association between TGF-beta1 gene expression and cervical cancer development has been suggested; however, the mechanisms by which HPV influences TGF-beta1 expression remain unclear. In the present study we analyzed the mechanism through which HPV-16 E6 and E7 oncoproteins regulate the TGF-beta1 promoter in cervical tumor cells. Our results showed that E6 and E7 increased TGF-beta1 promoter activity. Furthermore, we identified a specific DNA sequence motif in the TGF-beta1 core promoter that is responsible for trans-activation and that corresponds to the Sp1e-binding site associated with HPV-16 E6 and E7 oncoproteins. Mutational analysis showed that the Sp1e recognition site abolished the trans-activation caused by E6 and E7. These results suggest a physical interaction and functional cooperation between viral oncoproteins and cellular regulatory elements of the TGF-beta1 promoter, and may explain the contribution of HPV-16 to TGF-beta1 gene expression in cervical cancer.

摘要

人乳头瘤病毒(HPV)感染是宫颈癌的主要病因,HPV E6和E7癌基因可反式调节许多细胞基因。已有研究表明转化生长因子β1(TGF-β1)基因表达与宫颈癌发展之间存在关联;然而,HPV影响TGF-β1表达的机制仍不清楚。在本研究中,我们分析了HPV-16 E6和E7癌蛋白调节宫颈肿瘤细胞中TGF-β1启动子的机制。我们的结果表明,E6和E7增强了TGF-β1启动子活性。此外,我们在TGF-β1核心启动子中鉴定出一个特定的DNA序列基序,该基序负责反式激活,且与HPV-16 E6和E7癌蛋白相关的Sp1e结合位点相对应。突变分析表明,Sp1e识别位点消除了E6和E7引起的反式激活。这些结果表明病毒癌蛋白与TGF-β1启动子的细胞调节元件之间存在物理相互作用和功能协作,并可能解释HPV-16对宫颈癌中TGF-β1基因表达的作用。

相似文献

1
E6 and E7 oncoproteins from human papillomavirus type 16 induce activation of human transforming growth factor beta1 promoter throughout Sp1 recognition sequence.来自人乳头瘤病毒16型的E6和E7癌蛋白通过整个Sp1识别序列诱导人转化生长因子β1启动子的激活。
Viral Immunol. 2006 Summer;19(3):468-80. doi: 10.1089/vim.2006.19.468.
2
HPV16 E6 oncoprotein stimulates the transforming growth factor-beta 1 promoter in fibroblasts through a specific GC-rich sequence.人乳头瘤病毒16型E6癌蛋白通过一个特定的富含GC的序列刺激成纤维细胞中的转化生长因子-β1启动子。
Virology. 1997 Feb 17;228(2):190-9. doi: 10.1006/viro.1996.8363.
3
HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.人乳头瘤病毒16型癌基因E6或/和E7可能影响宫颈癌细胞系HT-3中RASSFIA基因启动子区域的甲基化状态。
Oncol Rep. 2017 Apr;37(4):2324-2334. doi: 10.3892/or.2017.5465. Epub 2017 Feb 17.
4
Transcriptional regulation of genes involved in keratinocyte differentiation by human papillomavirus 16 oncoproteins.人乳头瘤病毒16型癌蛋白对角质形成细胞分化相关基因的转录调控
Arch Virol. 2015 Feb;160(2):389-98. doi: 10.1007/s00705-014-2305-y. Epub 2014 Dec 7.
5
Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-beta2 (TGF-beta2) promoter.人乳头瘤病毒16型E6和E7癌基因对转化生长因子-β2(TGF-β2)启动子活性的影响。
Arch Virol. 2004 Dec;149(12):2379-92. doi: 10.1007/s00705-004-0376-x. Epub 2004 Jul 23.
6
Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells.烟草烟雾激活人乳头瘤病毒16型p97启动子,并与高危E6/E7协同作用,导致肺细胞中的DNA发生氧化损伤。
PLoS One. 2015 Apr 1;10(4):e0123029. doi: 10.1371/journal.pone.0123029. eCollection 2015.
7
Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.人乳头瘤病毒16型E6和E7蛋白抑制宫颈角质形成细胞中转化生长因子-β2的分化依赖性表达。
Cancer Res. 2000 Aug 1;60(15):4289-98.
8
Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.转录因子Sp1对人乳头瘤病毒18型E6-E7癌基因表达的激活作用
Nucleic Acids Res. 1992 Dec 25;20(24):6701-6. doi: 10.1093/nar/20.24.6701.
9
Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.环氧化酶-2转录受人类乳头瘤病毒16型E6和E7癌蛋白调控:共抑制因子/共激活因子交换的证据
Cancer Res. 2007 Apr 15;67(8):3976-85. doi: 10.1158/0008-5472.CAN-06-4273.
10
Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.16型乳头瘤病毒致癌基因可下调宫颈角质形成细胞中干扰素反应基因的表达,并上调增殖相关基因和NF-κB反应基因的表达。
J Virol. 2001 May;75(9):4283-96. doi: 10.1128/JVI.75.9.4283-4296.2001.

引用本文的文献

1
New mouse model based on adenocarcinoma 4T1 cells expressing HPV16 E6 and E7 applied to assess the efficacy of therapeutic and prophylactic E6/E7-based HPV16 vaccines.基于表达人乳头瘤病毒16型(HPV16)E6和E7的腺癌4T1细胞构建的新型小鼠模型,用于评估基于HPV16 E6/E7的治疗性和预防性疫苗的疗效。
Infect Agent Cancer. 2025 Jul 26;20(1):51. doi: 10.1186/s13027-025-00682-y.
2
Attributes of HPV associated cancers.人乳头瘤病毒相关癌症的特征。
Clin Transl Oncol. 2025 Jun 1. doi: 10.1007/s12094-025-03959-1.
3
Stromal Interferon Regulatory Factor 3 Can Antagonize Human Papillomavirus Replication by Supporting Epithelial-to-Mesenchymal Transition.
基质干扰素调节因子3可通过支持上皮-间质转化来拮抗人乳头瘤病毒复制。
Viruses. 2025 Apr 23;17(5):598. doi: 10.3390/v17050598.
4
Advances and Challenges in Cervical Cancer: From Molecular Mechanisms and Global Epidemiology to Innovative Therapies and Prevention Strategies.宫颈癌的进展与挑战:从分子机制、全球流行病学到创新疗法与预防策略
Cancer Control. 2025 Jan-Dec;32:10732748251336415. doi: 10.1177/10732748251336415. Epub 2025 Apr 23.
5
Molecular Insights into HR-HPV and HCMV Co-Presence in Cervical Cancer Development.宫颈癌发生过程中高危型人乳头瘤病毒(HR-HPV)与巨细胞病毒(HCMV)共同存在的分子机制洞察
Cancers (Basel). 2025 Feb 8;17(4):582. doi: 10.3390/cancers17040582.
6
The Hippo pathway transcription factors YAP and TAZ play HPV-type dependent roles in cervical cancer.Hippo 通路转录因子 YAP 和 TAZ 在宫颈癌中发挥 HPV 型依赖性作用。
Nat Commun. 2024 Jul 10;15(1):5809. doi: 10.1038/s41467-024-49965-9.
7
Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective.靶向转化生长因子-β异构体用于癌症治疗干预的进展与挑战:基于机制的视角
Pharmaceuticals (Basel). 2024 Apr 20;17(4):533. doi: 10.3390/ph17040533.
8
Efficacy and safety of bispecific antibodies vs. immune checkpoint blockade combination therapy in cancer: a real-world comparison.双特异性抗体与免疫检查点阻断联合疗法治疗癌症的疗效和安全性:真实世界比较。
Mol Cancer. 2024 Apr 16;23(1):77. doi: 10.1186/s12943-024-01956-6.
9
Haplotype Structures and Protein Levels of TGFB1 in HPV Infection and Cervical Lesion: A Case-Control Study.HPV 感染和宫颈病变中 TGFB1 的单体型结构和蛋白水平:一项病例对照研究。
Cells. 2022 Dec 25;12(1):84. doi: 10.3390/cells12010084.
10
Monoclonal antibodies in cervical malignancy-related HPV.宫颈癌相关人乳头瘤病毒中的单克隆抗体。
Front Oncol. 2022 Oct 6;12:904790. doi: 10.3389/fonc.2022.904790. eCollection 2022.